DOCK1 and breast cancer: Twist siRNA alone could increase the response of BC cells to cisplatin; however, when co-transfected with both Twist and DOCK1 siRNA, no significant difference in cell viability was observed between the Twist siRNA alone group and the Twist siRNA plus DOCK1 siRNA group (Fig. 6B).